---
category: news
title: "Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting"
excerpt: "Progenics Pharmaceuticals, Inc. PGNX, +0.74%, an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today announced that an abstract highlighting data from its PSMA AI program has been selected for a moderated poster presentation at the 2020 Society for Nuclear and Molecular Medicine (SNMMI) Mid-Winter Meeting,"
publishedDateTime: 2020-01-16T13:10:00Z
sourceUrl: https://www.marketwatch.com/press-release/progenics-pharmaceuticals-announces-presentation-at-the-2020-snmmi-mid-winter-meeting-2020-01-16
type: article
quality: 47
heat: 47
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: /assets/images/organizations/marketwatch.com-50x50.jpg
      width: 50
      height: 50

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png
    width: 1200
    height: 630
    title: "Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting"

secured: "uPqyf2oCBi5pRZg6a7/kBw8XDOnjbEgLA5pJDsTF9h9vPFOgn1up3xLHDduTReaEpTy0F0LXfch7nzvTXEPtelJiMltGJqB4mXBeo4AQ4keRAcGKude3Jq97/SOhnOPiSrM/Pzd/leGWhSFd5HDg+t+3GL0r/of/Zg9aTnzY3WHMqNaiipGhzE/xqN6WJ80B7447yiUyqJMUlRrSoSIuVF4l+gitA4wAuf302wigTEvyGpZLqSWWGrqf8iXQ2lkfdii5VGcOT/qOWtMO77GzV83Z322bM1FpaMDPwT+IcSg=;jfKbSd/MHxTYGSPbbK6twA=="
---

